Price (delayed)
$102.09
Market cap
$12.61B
P/E Ratio
18.36
Dividend/share
$0.28
EPS
$5.56
Enterprise value
$15.73B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.